Immunohistochemistry As an Important Tool in Biomarkers Detection and Clinical Practice
Overview
Authors
Affiliations
The immunohistochemistry technique is used in the search for cell or tissue antigens that range from amino acids and proteins to infectious agents and specific cellular populations. The technique comprises two phases: (1) slides preparation and stages involved for the reaction; (2) interpretation and quantification of the obtained expression. Immunohistochemistry is an important tool for scientific research and also a complementary technique for the elucidation of differential diagnoses which are not determinable by conventional analysis with hematoxylin and eosin. In the last couple of decades there has been an exponential increase in publications on immunohistochemistry and immunocytochemistry techniques. This review covers the immunohistochemistry technique; its history, applications, importance, limitations, difficulties, problems and some aspects related to results interpretation and quantification. Future developments on the immunohistochemistry technique and its expression quantification should not be disseminated in two languages-that of the pathologist and another of clinician or surgeon. The scientific, diagnostic and prognostic applications of this methodology must be explored in a bid to benefit of patient. In order to achieve this goal a collaboration and pooling of knowledge from both of these valuable medical areas is vital.
Yang L, Miao Z, Li N, Meng L, Feng Q, Qiao D Oncol Lett. 2025; 29(3):138.
PMID: 39839608 PMC: 11747855. DOI: 10.3892/ol.2025.14884.
Gold Nanoprism Enhanced SERS Aptasensor for Simultaneous Detection of Thrombin and VEGF.
Anantha P, Raj P, Zheng P, Tanwar S, Barman I Sens Actuators B Chem. 2025; 423.
PMID: 39744119 PMC: 11687365. DOI: 10.1016/j.snb.2024.136811.
Sathvik G, V P, Joseph L, Challa C Cureus. 2024; 16(9):e69929.
PMID: 39439618 PMC: 11495678. DOI: 10.7759/cureus.69929.
Antibody-Drug Conjugates and Their Potential in the Treatment of Patients with Biliary Tract Cancer.
Alexander S, Aleem U, Jacobs T, Frizziero M, Foy V, Hubner R Cancers (Basel). 2024; 16(19).
PMID: 39409965 PMC: 11476249. DOI: 10.3390/cancers16193345.
Pati P, Karkampouna S, Bonollo F, Comperat E, Radic M, Spahn M Nat Mach Intell. 2024; 6(9):1077-1093.
PMID: 39309216 PMC: 11415301. DOI: 10.1038/s42256-024-00889-5.